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Methicillin and oxacillin hydrolyzing enzymes of 6 borderline methicillin-resistant and 1 
methicillin-resistant Staphylococcus aureus strains isolated from human clinical samples and 
4 borderline methicillin-resistant S. aureus strains isolated from bovine mastitis were 
investigated. As previous studies suggested the involvement of an additional enzyme besides 
the penicillinase BlaZ in the determination of borderline resistance, we analyzed the 
expressed extracellular and membrane-bound ß-lactamases with 2-D gel electrophoresis and 
mass spectrometry. Our analysis showed that the penicillin-hydrolyzing BlaZ alone was 
responsible for the hydrolysis of both methicillin and oxacillin. All supernatant and 
membrane fractions contained the same enzyme with slight sequence variations. The size and 
pI of the proteins were also variable, probably due to spontaneous hydrolysis and/or post-
translational modifications. Interestingly, we found also cytotoxins and other virulence factors 
in some nitrocefin hydrolyzing dots, suggesting that those proteins might have a role in the 
reduction of local antibiotic concentration. 
 
 
Key words: Staphylococcus aureus, borderline methicillin-resistance, membrane-bound β-
lactamase, penicillinase, PRPs-hydrolysing enzyme, proteomics.
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Methicillin and the other penicillinase-resistant penicillins (PRPs), are narrow spectrum 
semisynthetic penicillins that share the property of being stable to the staphylococcal β-
lactamase. Shortly after methicillin was introduced into clinical practice, methicillin-resistant 
Staphylococcus aureus (MRSA) strains emerged and spread rapidly since then (de Lencastre 
et al., 2007). In contrast to penicillin-resistance that is due to the production of β-lactamase, a 
penicillinase encoded by the blaZ gene, methicillin-resistance is due to the production of a 
penicillin-binding protein with reduced affinity to ß-lactams, encoded by the mecA gene. 
A distinct mechanism seems to account for the low-level or borderline resistance of S. 
aureus to methicillin and the other PRPs. Typical borderline methicillin-resistant S. aureus 
strains have an oxacillin MIC. between 2 and 4 μg/ml, produce large amounts of β-lactamase 
and become susceptible to PRPs in the presence of β-lactamase inhibitors (Massidda et al., 
1996). In addition, different from truly MRSA, that may show similar MICs to oxacillin, they 
do not carry the mecA gene. These β-lactamase hyperproducer strains harbour plasmids that 
encode a type A staphylococcal penicillinase, BlaZ (Chambers, 1997). The borderline 
phenotype was initially attributed solely to the hyperproduction of the BlaZ (McDougal and 
Thornsberry, 1986). Subsequent studies revealed that some borderline strains produce a second 
β-lactamase, a membrane-bound methicillinase, able to hydrolyse PRPs (Gál et al., 2001; 
Kaszanyitzky et al., 2004; Keserű et al., 2005; Massidda et al., 1992). This enzymatic activity 
did not appear to be due to BlaZ (Massidda et al., 2006; Massidda et al., 1994, 1996).  
In this paper our aim was to identify the PRP-hydrolyzing enzyme by proteomic analysis 
of the extracellular and membrane-bound ß-lactamases of previously characterized borderline 
S. aureus strains isolated from clinical samples derived from different species. 
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2.1. Bacterial strains and growth conditions 
 
10 borderline methicillin-resistant and 1 MRSA isolates (Table 1) were included in the 
study. The bovine isolates were selected from a previously described collection (Kaszanyitzky 
et al., 2004), accordingly to the guidelines specified by the CLSI (Clinical and Laboratory 
Standards Institute, former National Committee for Clinical Laboratory Standards, [NCCLS]) 
(National Committee for Clinical Laboratory Standards, 2000). The human isolates were 
selected according to the same criteria as bovine isolates as described (Gál et al., 2001; 
Kaszanyitzky et al., 2004; Keserű et al., 2005; Massidda et al., 1992). The discrimination 
between borderline methicillin-resistant strains that were truly MRSA was done testing mecA 
(Table 1) as previously described (Gál et al., 2001; Keserű et al., 2005; Massidda et al., 1996). 
Bacteria were grown in a 1% CY (casein – yeast) broth prepared as described (Novick and 
Brodsky, 1972) and supplemented with 0.5 μg/ml methicillin to induce β-lactamase 
production. 
 
2.2. Preparation of bacterial supernatants 
 
Cells were harvested by centrifugation at 4000 g for 30 min at 4ºC. 50 ml aliquots of 
supernatants were filtered via a Millipore sterile filter (0.45 µm) then concentrated with 
ultrafiltration (PM-10 membrane, Amicon) and with Centricon YM-3 Centrifugal Filter Units 
(Millipore). 
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Harvested cells were washed twice with a 50 mM sodium-phosphate-buffer (pH 7.0), 
resuspended in the same buffer containing 1 mg/ml lysozyme (Sigma), then were incubated at 
37ºC for 1.5 h. The intact cells were pelleted by centrifugation at 1100 g for 10 min at 4ºC 
and the protoplasts were collected by centrifuging the supernatant at 27000 g for 20 min at 
4ºC. The protoplasts were resuspended in distilled water for 5 min then 0.5 mg/ml MgCl2 and 
0.09 mg/ml DNase were added. The burst protoplasts were incubated at 37ºC for 1 h then 
centrifuged at 3000 g for 10 min at 4ºC. Cellular membrane fractions were collected by 
centrifugation of the supernatant at 27000 g for 20 min at 4ºC, then washed three times with 
distilled water and stored at -20ºC. 
When the yield of that protocol was not satisfactory cells were sonicated by Branson 
Sonifier 250 (micro tip limit output control = 3; 50% duty cycle; on ice) then centrifuged at 
3000 g for 10 min at 4ºC to remove heavy cell degradation products. Cellular membrane 
fractions were collected also by centrifugation of the supernatant at 27000 g for 20 min at 
4ºC. 
Because of the high lysozyme-resistance of strain a53 French press was used to disrupt the 
cells and whole cell lysate was used instead of membrane fraction. 
 
2.4. 2-D gel electrophoresis of extracellular proteins 
 
100-100 µg of concentrated proteins were precipitated and desalted using the ReadyPrepTM 
2-D Cleanup Kit (Bio-Rad Laboratories), then redissolved in 125-125 μl of rehydration buffer 
(IEF buffer, sample buffer) containing 8 M urea, 2% CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate), 0.2% 3/10 IPG (immobilized pH 
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gradient) buffer (Bio-Rad Laboratories), 50 mM DTT (dithiothreitol) and 0.002% 
Bromophenol Blue. For first-dimension isoelectric focusing (IEF) 7 cm pH 3-10 IPG strips 
(Bio-Rad Laboratories) were rehydrated overnight in IEF buffer containing the sample at 
room temperature in a rehydration/equilibration tray. IEF was performed using Bio-Rad 
Protean IEF Cell. Proteins on the IPG strips were focused at 20ºC at 4000 V to a total of 
10000 Vh initiated by a slow voltage gradient from 0 to 250 V in 20 min, then from 250 V to 
4000 V in 2 h. Following the IEF, IPG strips were processed for the second-dimension 
separation by a 10 min equilibration in 6 M urea, 2% SDS (sodium dodecyl sulfate, or sodium 
lauryl sulfate), 50 mM Tris-HCl (pH 8.8), 30% glycerol, 1% DTT followed by a second 10 
min bath in a similar solution in which DTT was replaced by 2.5% iodoacetamide. Second 
dimension separation was performed essentially as described (Laemmli, 1970). Strips were 
applied to a Mini-Protean 2-D Cell (Bio-Rad Laboratories, Paris) with a 5% stacking gel, 13% 
separating gel and electrophoresis was performed at constant voltage of 200 V. 
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2.5. 2-D gel electrophoresis of membrane proteins 
 
100-100 µg sample was desalted with ReadyPrep™ 2-D Cleanup Kit (Bio-Rad 
Laboratories, Paris) and was dissolved in maximum 50 µl rehydration buffer containing 7 M 
urea, 2 M thiourea, 2% CHAPS, 0.2% 3/10 IPG buffer, 50 mM DTT and 0,002% 
Bromophenol Blue. 
Isoelectric focusing was performed using Bio-Rad Protean IEF Cell. 7 cm long pH 3-10 
IPG strips were incubated for 16 h at room temperature with 135-135 µl sample buffer 
without sample. Samples were applied before IEF via cups at the anodic site. IPG strips were 
focused at 20 ºC and the following voltage gradient was applied: from 0 to 250 V in 30 min, 
from 250 to 4000 V in 2 h and 4000 V to 10000 Vh.  
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In case of the whole cell lysate of strain a53 350 – 350 µg protein was applied to 17 cm 
long pH 3-10 strips in 100 µl. The strips were rehydrated in 330 – 330 µl of sample buffer. 
Samples were applied before IEF via cups at the anodic site. IPG strips were focused at 20 ºC 
and the following voltage gradient was applied: from 0 to 250 V in 30 min, from 250 to 
10000 V in 2 h and 10000 V to 40000 Vh. 
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After isoelectric focusing the strips were handled as in the case of extracellular proteins. 
 
2.6. Detection of β-lactamases on SDS-PA gels 
 
Membrane and culture supernatant fractions (100 μg of total protein) were subjected to IEF 
and SDS-polyacrylamide gel electrophoresis (PAGE) in duplicates. One of the gels was 
soaked in a renaturating buffer for 6-8 h at 37˚C (Massidda et al., 1992). Enzymatic activity 
was detected directly by placing: filter paper strips soaked in 1 mg/ml nitrocefin (O'Callaghan 
et al., 1972) solution on the appropriate areas of the gels corresponding to areas where we 
detected activities on 1-D SDS-PAGE previously (Kaszanyitzky et al., 2004; Keserű et al., 
2005; Massidda et al., 1994). After the detection and marking of the β-lactamase dots or 
bands the gels were stained with Coomassie Brilliant Blue G-250 (Blue Silver) (Candiano et 
al., 2004). 
The paralell gels were stained with Coomassie Brilliant Blue G-250 and appropriate spots 
were cut out a from the gels. 
 
2.7. Mass spectrometric analysis 
 
MALDI-TOF analysis was performed as described by Birkó et al. (Birkó et al., 2009). 
Peak picking was done manually, using X-Mass/X-Tof (ver.: 5.1.1) software from Bruker 
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Daltonics. Peak lists were subjected to database search either using ProteinProspector MS-Fit 
on-line search engine or Mascot. 
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LC-MS/MS analyses were carried out on an Agilent XCT Plus ion trap mass spectrometer 
on-line coupled with an Agilent 1100 nano-HPLC system. An aliquot of the samples were 
injected to a Zorbax 300SB-C18 5μm 5×0,3 mm trap column and washed onto the nano 
column (Zorbax 300SB-C18 3,5 μm 150 × 0,75 mm) using a short gradient elution of 5-45% 
solvent B in 20 min (flow rate: 300 nl/min, solvent A: 0.1% formic acid in water, solvent B: 
0.1% formic acid in acetonitrile). Mass spectrometric analyses were carried out using 
information dependent mode acquiring the MS/MS spectra of the three most intense multiply 
charged precursor cations. 
To identify the proteins present, mass spectrometry data were searched against the 
unrestricted NCBI protein database [NCBInr 20070926 (5519594 sequences)] using the 
Mascot search engine. The parameters used for the database search identical to those 
described by Birkó et al. (Birkó et al., 2009). Protein lists were revised manually taking into 
consideration only the significant peptide hits (p<0.05), minimum two significant 
peptides/protein. 
 
 
3. Results 
 
3.1. Analysis of the extracellular ß-lactamases 
 
For the analysis of extracellular enzymes we used the conventional rehydration buffer and 
technique of sample preparation and of IEF. One pair of representative gel pictures (Fig. 1) 
shows the result obtained with the supernatant fraction of strain VU94. ß-lactamase activity 
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appeared in wide areas of the gels (Fig. 1A). In most cases we found enzymes at pI 4, 5 and 9. 
All active dots were analyzed (1-10 dots/gel), and the unambiguously identified proteins are 
listed in Table 2. At least 42% of the significant peaks match with the database peptides of the 
appropriate protein in case of MALDI-TOF, and at least 5 peptide fragments in case of LC-
MS/MS analysis. 
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In all cases BlaZ (gi|33416277) was identified as the extracellular ß-lactamase (Table 2). In 
strain 7789/47 a BlaZ variant (gi|3603441, erroneously called “type b” ß-lactamase), and in 
strain 7789/98 its longer variant (gi|67973147) was found together with BlaZ (gi|33416277) 
or alone . The “type b” variants differed slightly (7 %) from BlaZ because of the presence of a 
peptide with molecular weight of 1440 Da corresponding to 34YNANIGVYALDTK46 tryptic 
fragment with an ion score of 89. In gi|33416277 BlaZ H is present instead of the underlined 
N. In case of 7789/47 we also found a peptide with molecular weight of 1543 Da 
corresponding to 
215 
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245GQSEPIVLVIFTNK258 (ion score was 87), which is present in 
gi|33416277 BlaZ (in gi|3603441 it is not present, in gi|67973147 N is present instead of the 
underlined G, and I is present instead of the underlined V). This probably represents a new 
sequence variant of BlaZ in this strain. In strain 7789/98 a peak with molecular weight of 
1973 (
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245GQSEPIVLVIFTNKDNK261) instead of 1902 (245NQSEPIILVIFTNKDNK261) was 
found, and also some other characteristic differences are labelled with asterisks on the 
spectrograms on Supplemental Figure 1. 
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Besides BlaZ hemolysins (α-hemolysin in strains a53, a36, 9800, 9989, and 14287, ß- 
hemolysin in strains 822 and 14287, truncated ß- hemolysin in strain 14287, γ-hemolysin in 
strain 9989), some lipases (lipase 1 and 2 in strain 9800) and other cytotoxins and virulence 
factors (leukocidin in strains a53 and a36, serine protease SplB in strains a53 and 14287/1) 
were also able to hydrolyze nitrocefin (data not shown). 
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3.2. Analysis of the membrane-bound ß-lactamases 231 
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In human samples the membrane-bound enzymes were attached to the membrane via a 
thioether-bond (Gál et al., 2001; Keserű et al., 2005), so we used a modified rehydration 
buffer and cup-loading technique to dissolve and apply the membrane proteins to the strips. 
One representative pair of gels (Fig. 2), shows the result obtained with the membrane fraction 
of strain VU94. 
Similarly to the supernatant fractions we found enzymes at pI 4, 5 and 9 on the gels. All 
the active dots were analyzed (1-4 dots/gel), and the unambiguously identified proteins are 
listed in Table 3. At least 50% of the significant peaks match with the database peptides of the 
appropriate protein in case of MALDI-TOF, and at least 3 peptide fragments giving protein 
score larger than 25 in case of LC-MS/MS analysis. 
All of the membrane fractions contained the same BlaZ (gi|33416277). In strains 7789/47 
and 7789/98 a longer and a shorter “type b” BlaZ variant was found (gi|67973147 and 
gi|3603441, respectively). In case of strain 7789/98 we detected a peptide with molecular 
weight of 1097 Da, which corresponded to 146LGDKVTNPVR155 tryptic fragment with an ion 
score of 34. This can be produced only, when at position 145 a Lysine (gi|3603441, 
gi|67973147) is present and not Glutamic acid (gi|33416277). We also found a peptide with 
molecular weight of 1568 Da corresponding 33KYNANIGVYALDTK46 (ion score was 82), 
which is present in gi|3603441 and in gi|67973147 BlaZ (in gi|33416277 H replaces the 
underlined N). This probably represents a new sequence variant of BlaZ in this strain. On the 
mass spectrogram of strain 7789/47 we found the same differences like in the case of the 
spectrogram of the extracellular enzyme of strain 7789/98, so probably both strains contain 
the same sequences variant. 
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4. Discussion 256 
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Our results show that all β-lactamase activities detectable in the supernatant and the 
membrane fractions of the borderline methicillin-resistant S. aureus isolates, derived from 
human or bovine clinical samples, were all attributable to the BlaZ penicillinase produced by 
these strains. All BlaZ proteins detected are highly similar to each other, however slight 
sequence variations seem common and may account for the different size and, probably, the 
substrate specificity of the proteins (Voladri et al., 1996; Zawadzke et al., 1995). In strains 
7789/47 and 7789/98 an additional enzyme with slight sequence variations was found. 
Interestingly, in the supernatant fractions besides BlaZ that constitutes the main part of the 
ß-lactamase activity detected, we found cytotoxins and other virulence factors in some 
nitrocefin hydrolyzing dots. It was established that some ß-lactam antibiotics are able to 
trigger (Kernodle et al., 1995) and some ß-lactamase inhibitors are able to inhibit the 
production of hemolysins (Tawfik et al., 1996). So, hemolysin production seems to be 
connected to the presence of ß-lactams and thus may have a role in the reduction of local 
antibiotic concentration. 
BlaZ was the only ß-lactamase activity found in the membrane fractions and in the whole 
cell extract of the borderline methicillin-resistant S. aureus strain a36 and a53, as shown in 
Fig. 2 (see spots M1 and M2, respectively). A likely explanation is that the two bands 
originally seen on SDS-PAGE renatured gels (Massidda et al., 1996; Massidda et al., 1992) 
contained the same protein with different sizes rather than two distinct ß-lactamases. These 
results do not confirm the previous hypothesis proposing that a second ß-lactamase, distinct 
from BlaZ, was responsible for the hydrolysis of PRPs in borderline strains (Massidda et al., 
1996). However, the argument was based on the experimental findings that a recombinant E. 
coli strain, constitutively expressing the blaZ gene from a borderline strain, was not able to 
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hydrolyse PRPs (Massidda et al., 1996) and the blaZ gene showed a wild-type sequence 
(Massidda et al., 2006) and did not rule out different posttranslational modifications that 
could occur in a borderline methicillin-resistant background. 
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The different size and perhaps the substrate specificity of the same enzyme could be the 
consequence of the proteolysis of ß-lactamases or posttranslational modification. A 
posttranslational modification (mainly phosphorylation) can explain the shift in the pI of the 
proteins. There are 23 Serine, 13 Threonine, and 13 Tyrosine residues in BlaZ, which can be 
phosphorylated. When 20 of them are phosphorylated it shifts the pI from 9.55 to 7 (result by 
ProMoST: Protein Modification Screening Tool, University of Wisconsin, Madison, Medical 
College of Wisconsin, Proteomics Center), so phosphorylation of all possible sites can shift 
the pI to 5 or 4 easily, and phosphate groups (MW: 95) also can cause an increase in the 
molecular weight of the protein. The 23 Asparagines and 4 Glutamines can be spontaneously 
hydrolyzed to Aspartic acid and Glutamic acid, respectively, which also can alter the pI 
(Zomber et al., 2005). 
Bovine strains contained the same BlaZ ß-lactamase like the human ones. Moreover, in 
two strains (7789/98 and 7789/47) we found an enzyme called erroneously type-b ß-lactamase 
and its longer variant, having 7% sequence divergence compared to the gi|33416277 
sequence. During the selection of the bovine strains also the phage type of them was 
established in the phage laboratory of the Hungarian National Public Health and Medical 
Officer Service, Debrecen, Hungary (unpublished data), and it showed that the 17599/3A and 
17599/3B isolates could not been typed with bovine series of phages but only with the human 
series, suggesting that those strains may have a human origin. It is interesting that “type-b” ß-
lactamase or its longer variant was found only in strains with bovine origin. In these strains 
the shorter and longer variants of “type b” BlaZ were found alternatively in the supernatant or 
membrane fractions. It is also possible that the longer variant is present in all cases, but we 
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could not detect the C-terminal fragments. Because in the supernatant of strain 7789/47 a 
peptide also was identified that can be found in BlaZ (gi|33416277) we suppose that two 
enzymes are present in this strain, or it is more likely that a sequence variant that is not found 
in NCBI database is present in both strains. 
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5. Conclusion 
 
In summary our results show that all ß-lactamase activities dectectable in the supernatant 
and the membrane fractions of our borderline methicillin-resistant S. aureus isolates, derived 
from human or bovine clinical samples, were similar and all attributable to the BlaZ 
staphylococcal penicillinase produced by these strains. In many isolates an extracellular and a 
membrane-bound form of ß-lactamase were present. The extracellular form might have role in 
the reduction of local antibiotic concentration, while the membrane-bound enzyme could act 
at a more concentrated way. The “type-b” sequence variants were found only in the cow 
isolates. In two cases, it was shown that the bovine isolates have a human origin. 
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Table 1. Methicillin-resistant and borderline methicillin-resistant Staphylococcus aureus 
isolates of human and animal origin 
408 
409 
Designation Source mecA ß-lactamase 
production 
Origin 
VU94 human - type A, extracellular 
and membrane-bound
provided by Dr. D. S. Kernodle 
(Vanderbilt University, Nashville, 
Tennessee, USA) 
a53 human - type A, extracellular 
and membrane-bound
clinical isolate from the collection of 
the Institute of Microbiology, 
University of Ancona Medical 
School, Italy 
a36 human - type A, extracellular 
and membrane-bound
clinical isolate from the collection of 
the Institute of Microbiology, 
University of Ancona Medical 
School, Italy 
822 
(MRSA) 
human + type A, extracellular 
and membrane-bound
clinical isolate from the collection of 
the Department of Microbiology, 
University of Debrecen, Hungary 
9800 human - type A, extracellular 
and membrane-bound
clinical isolate from the collection of 
the Department of Microbiology, 
University of Debrecen, Hungary 
9989 human - type A, extracellular 
(weak) and 
membrane-bound 
clinical isolate from the collection of 
the Department of Microbiology, 
University of Debrecen, Hungary 
14287 human - type A, extracellular 
and membrane-bound
clinical isolate from the collection of 
the Department of Microbiology, 
University of Debrecen, Hungary 
17599/3A bovine - type A, extracellular 
and membrane-bound
isolate from Central Veterinary 
Institute, Hungary 
17599/3B bovine - type A, extracellular 
and membrane-bound
isolate from Central Veterinary 
Institute, Hungary 
7789/47 bovine - type A extracellular 
and membrane-bound
isolate from Central Veterinary 
Institute, Hungary 
7789/98 bovine - type A, extracellular 
and membrane-bound
isolate from Central Veterinary 
Institute, Hungary 
 410 
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Table 2. Nitrocefin-hydrolyzing extracellular enzymes of methicillin-resistant and borderline methicillin-resistant Staphylococcus aureus strains 411 
Sample1 NCBI-GI Protein name Match2 Seq. 
Cov. 
%3
Nominal 
mass Mr
pI 
on 
gel 
Theore-
tical pI 
PSD or Mascot Score or MS/MS 
Search Score  
VU94 / E1 gi|33416277 Beta-lactamase (BlaZ) 23/43 55 31349.5 4 9.55 125SGQAITYASR134
VU94 / E2 gi|33416277 Beta-lactamase (BlaZ) 25/46 69 31349.5 5 9.55 55NDVAFVYPK63
VU94 / E3 gi|33416277 Beta-lactamase (BlaZ) 26/57 67 31349.5 9 9.55 61FAYASTSK68
a53 / E1 gi|33416277 Beta-lactamase (BlaZ) 25/32 64 31349.5 3.5 9.55  
a53 / E2 gi|33416277 Beta-lactamase (BlaZ) 24/35 60 31349.5 4.5 9.55 150VTNPVRYEIELNYYSPK166
a53/ E3 gi|33416277 Beta-lactamase (BlaZ) 22/37 49 31349.5 9 9.55  
a36 / E1 gi|33416277 Beta-lactamase (BlaZ) 17/37 47 31349.5 4.5 9.55 524
a36 / E2 gi|33416277 Beta-lactamase (BlaZ) 7/14 30 31349.5 5 9.55  
a36 / E3 gi|33416277  Beta-lactamase (BlaZ) 17/20 45 31349.5 9 9.55 1194
822 / E1 gi|33416277 Beta-lactamase (BlaZ) 18/27 64 31349.5 4 9.55 55NDVAFVYPK63
822 / E2 gi|33416277 Beta-lactamase (BlaZ) 21/35 46 31349.5 5 9.55 125SGQAITYASR134
822 / E3 gi|33416277 Beta-lactamase (BlaZ) 18/25 59 31349.5 9 9.55 61FAYASTSK68
9800 / E1 gi|33416277 Beta-lactamase (BlaZ) 7 23 31349.5 5 9.55 90 
14287 / E1 gi|33416277  Beta-lactamase (BlaZ) 23/38 58 31349.5 9 9.55 1144
14287 / E2 gi|33416277 Beta-lactamase (BlaZ) 11/26 50 31349.5 8 9.55 236NDVAFVYPK244
14287 / E3 gi|33416277 Beta-lactamase (BlaZ) 38/43 79 31349.5 5 9.55 2014
14287 / E4 gi|33416277 Beta-lactamase (BlaZ) 17/23 57 31349.5 4 9.55 1024
17599/3A / E1 gi|33416277 Beta-lactamase (BlaZ) 9 31 31349.5 4 9.55 323 
17599/3B / E1 gi|33416277 Beta-lactamase (BlaZ) 21 64 31349.5 5 9.55 322 
7789/47 / E1 gi|3603441 “Type b” beta-lactamase 
(BlaZ) 
5 23 27197 4.5 9.74 387 
7789/47 / E1 gi|33416277 Beta-lactamase (BlaZ) 5 22 31349.5 4.5 9.55 381 
7789/98 / E1 gi|67973147 Beta-lactamase (BlaZ) 13/16 44 29205 4 9.72  
1E1, E2, etc. correspond to the different active dots of the same gel 412 
413 2MALDI-TOF: Matched/observed masses, LC-MS: Total number of distinct peptides 
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3Sequence covered 414 
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416 
4Mascot score 
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Table 3. Nitrocefin-hydrolyzing membrane-bound enzymes of methicillin-resistant and borderline methicillin-resistant Staphylococcus aureus 
strains 
417 
418 
Sample1 NCBI-GI Protein name Match2 Seq. 
Cov. 
%3
Nominal 
mass Mr
pI on 
gel4
Theore-
tical pI 
PSD or MS/MS 
Search Score or 
Mascot Score 
VU94 / M1 gi|33416277 Beta-lactamase (BlaZ) 26 71 31349.5 9 9.55 385.4 
VU94 / M2 gi|33416277 Beta-lactamase (BlaZ) 6 24 31349.5 9 9.55 89.36 
VU94 / M3 gi|33416277 Beta-lactamase (BlaZ) 23 70 31349.5 5 9.55 331.54 
VU94 / M4 gi|33416277 Beta-lactamase (BlaZ) 29 74 31349.5 4 9.55 465.03 
a53 / M1 gi|33416277 Beta-lactamase (BlaZ) 13/26 36 31349.5 4 9.55 1135
a53 / M2 gi|33416277 Beta-lactamase (BlaZ) 30/40 70 31349.5 4 9.55 2135
a36 / M1 gi|33416277 Beta-lactamase (BlaZ) 18/51 65 31349.5 4 9.55 69FAYASTSK76
822 / M1 gi|33416277 Beta-lactamase (BlaZ) 5 13 31349.5 4.5 9.55 61.47 
822 / M2 gi|33416277 Beta-lactamase (BlaZ) 6 23 31349.5 5 9.55 88.06 
9800 / M1 gi|33416277 Beta-lactamase (BlaZ) 33 82 31349.5 4.5 9.55 479.83 
9800 / M2 gi|33416277 Beta-lactamase (BlaZ) 22 71 31349.5 9 9.55 326.37 
9989 / M1 gi|33416277 Beta-lactamase (BlaZ) 22 70 31349.5 4.5 9.55 337.3 
14287 / M1 gi|33416277 Beta-lactamase (BlaZ) 10/12 40 31349.5 4 9.55 715
14287 / M2 gi|33416277 Beta-lactamase (BlaZ) 15/41 51 31349.5 4 9.55 1005
17599/3A / M1 gi|33416277 Beta-lactamase (BlaZ) 32 79 31349.5 4 9.55 462.3 
17599/3A / M2 gi|33416277 Beta-lactamase (BlaZ) 11 39 31349.5 9 9.55 160.42 
17599/3A / M3 gi|33416277 Beta-lactamase (BlaZ) 21 64 31349.5 5 9.55 308.9 
17599/3A / M4 gi|33416277 Beta-lactamase (BlaZ) 26 76 31349.5 9 9.55 404.04 
17599/3B / M1 gi|33416277 Beta-lactamase (BlaZ) 36 79 31349.5 4 9.55 560.16 
17599/3B / M2 gi|33416277 Beta-lactamase (BlaZ) 38 79 31349.5 5 9.55 562.1 
17599/3B / M3 gi|33416277 Beta-lactamase (BlaZ) 12 45 31349.5 9 9.55 181.87 
7789/47 / M1 gi|67973147 Beta-lactamase (BlaZ) 28/45 70 29205 8.5 9.72 1305
7789/98 / M1 gi|3603441 “Type b” beta-lactamase (BlaZ) 4 17 27197 3.5 9.74 1945
7789/98 / M2 gi|3603441 “Type b” beta-lactamase (BlaZ) 3 13 27197 4 9.74 1815
1M1, M2, etc. correspond to different active dots of the same gel 419 
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2MALDI-TOF: Matched/observed masses, LC-MS: Total number of distinct peptides 420 
421 
422 
423 
424 
3 Sequence covered 
4Different proteins having the same pI in the case of the same strains mean different observed molecular weight on the gel 
5Mascot score 
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Fig. 1. 2-D gel electrophoresis pattern of the supernatant fraction proteins of borderline 
methicillin-resistant Staphylococcus aureus strain VU94. (A): The gel was regenerated, and 
the nitrocefin hydrolyzing activities detected. (B): Blue Silver stained 2-D gel. The encircled 
areas are equivalent to the nitrocefin-hydrolyzing areas on (A). The + sign shows the acidic 
(pH 3) end. 
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Fig. 2. 2-D gel electrophoresis pattern of the membrane fraction proteins of borderline 
methicillin-resistant Staphylococcus aureus strain VU94. (A): The gel was regenerated, and 
the nitrocefin hydrolyzing activities detected. (B): Blue Silver stained 2-D gel. The encircled 
areas are equivalent to the nitrocefin-hydrolyzing areas on (A). The + sign shows the acidic 
(pH 3) end. 
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Suppl. Fig. 1.: Comparison of the spectra of BlaZ sequence variants. (A): Typical MALDI-
TOF MS mass spectrum of gi|33416277 ß-lactamase present in 14287/E3 sample. 38 matched 
out of 43 detected masses. The corresponding peptides covered 79 % of the protein sequence. 
(B): MALDI-TOF MS spectrum of 7789/98/E1 sample. 13 out of 16 detected peaks matched 
to the gi|67973147 beta-lactamase protein sequence. Sequence coverage was 44%. Asterisks 
show the peptides characteristic to the BlaZ sequence variants. 
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